Chia-Feng Lu

Chia-Feng Lu

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2018 in IEEE Transactions on Neural Systems and Rehabilitation Engineering
Verified
Journal Article
Closed access
YLYan-Ci Liu
Yan-Ci Liu
YYYea-Ru Yang
Yea-Ru Yang
YTYun-An Tsai
Yun-An Tsai
WYWang Ray Yau
Wang Ray Yau
CLChia-Feng Lu
Chia-Feng Lu
This study investigated the effects of cognitive and motor dual tasks on gait performance and brain activities in stroke. Twenty-three stroke subjects performed single walking (SW), walking while performing cognitive task (WCT), and walking while performing motor task (WMT) at self-selected speed. The gait performance was recorded, including speed, cadence, stride time, stride length, and dual task cost (DTC). Brain activities in prefrontal cortex (PFC), premotor cortex (PMC), and supplementary motor areas (SMA) were measured by functional near-infrared spectroscopy during walking. Results showed significant decrease in speed, cadence, and stride length, and increase in stride time were noted in both WCT and WMT compared with SW condition. There was no significant difference in DTC between WCT and WMT. The non-lesioned SMA and most channels of bilateral PMCs exhibited significant increases in the index of hemoglobin differential during WCT and WMT compared with SW. Moreover, gait performance was negatively correlated with bilateral PMCs and lesioned SMA during different walking tasks. In conclusion, deteriorated gait performance was noted in stroke attempting dual tasks. No significant difference between the two dual tasks on gait performance. Nevertheless, SMA and especially PMC were crucial in cognitive and motor dual task walking after stroke.

1 February 2021 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
Huai-Che YangHuai-Che Yang
Huai-Che Yang
CWChih-Chun Wu
Chih-Chun Wu
CLCheng-Chia Lee
Cheng-Chia Lee
HHHuai-En Huang
Huai-En Huang
WLWei-Kai Lee
Wei-Kai Lee
CLChia-Feng Lu
Chia-Feng Lu

10 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
CLChien-Yi Liao
Chien-Yi Liao
CLCheng-Chia Lee
Cheng-Chia Lee
HYHuai-Che Yang
Huai-Che Yang
CCChing-Jen Chen
Ching-Jen Chen
WCWen-Yuh Chung
Wen-Yuh Chung
CLChia-Feng Lu
Chia-Feng Lu
The diagnosis of brain metastasis (BM) is commonly observed in non-small cell lung cancer (NSCLC) with poor outcomes. Accordingly, developing an approach to early predict BM response to Gamma Knife radiosurgery (GKRS) may benefit the patient treatment and monitoring. A total of 237 NSCLC patients with BMs (for survival prediction) and 256 patients with 976 BMs (for prediction of local tumor control) treated with GKRS were retrospectively analyzed. All the survival data were recorded without censoring, and the status of local tumor control was determined by comparing the last MRI follow-up in patients’ lives with the pre-GKRS MRI. Overall 1763 radiomic features were extracted from pre-radiosurgical magnetic resonance images. Three prediction models were constructed, using (1) clinical data, (2) radiomic features, and (3) clinical and radiomic features. Support vector machines with a 30% hold-out validation approach were constructed. For treatment outcome predictions, the models derived from both the clinical and radiomics data achieved the best results. For local tumor control, the combined model achieved an area under the curve (AUC) of 0.95, an accuracy of 90%, a sensitivity of 91%, and a specificity of 89%. For patient survival, the combined model achieved an AUC of 0.81, an accuracy of 77%, a sensitivity of 78%, and a specificity of 80%. The pre-radiosurgical radiomics data enhanced the performance of local tumor control and survival prediction models in NSCLC patients with BMs treated with GRKS. An outcome prediction model based on radiomics combined with clinical features may guide therapy in these patients.

4 August 2022 in Cancers
Verified
Journal Article
Open access
PDF file
KHKuei-Yuan Hou
Kuei-Yuan Hou
JCJyun-Ru Chen
Jyun-Ru Chen
YWYung-Chen Wang
Yung-Chen Wang
MCMing-Huang Chiu
Ming-Huang Chiu
SLSen-Ping Lin
Sen-Ping Lin
CLChia-Feng Lu
Chia-Feng Lu
Patient outcomes of non-small-cell lung cancer (NSCLC) vary because of tumor heterogeneity and treatment strategies. This study aimed to construct a deep learning model combining both radiomic and clinical features to predict the overall survival of patients with NSCLC. To improve the reliability of the proposed model, radiomic analysis complying with the Image Biomarker Standardization Initiative and the compensation approach to integrate multicenter datasets were performed on contrast-enhanced computed tomography (CECT) images. Pretreatment CECT images and the clinical data of 492 patients with NSCLC from two hospitals were collected. The deep neural network architecture, DeepSurv, with the input of radiomic and clinical features was employed. The performance of survival prediction model was assessed using the C-index and area under the curve (AUC) 8, 12, and 24 months after diagnosis. The performance of survival prediction that combined eight radiomic features and five clinical features outperformed that solely based on radiomic or clinical features. The C-index values of the combined model achieved 0.74, 0.75, and 0.75, respectively, and AUC values of 0.76, 0.74, and 0.73, respectively, 8, 12, and 24 months after diagnosis. In conclusion, combining the traits of pretreatment CECT images, lesion characteristics, and treatment strategies could effectively predict the survival of patients with NSCLC using a deep learning model.

30 September 2024 in Cancer Imaging
Verified
Journal Article
Open access
PDF file
CLChien-Yi Liao
Chien-Yi Liao
YCYuh-Min Chen
Yuh-Min Chen
YWYu-Te Wu
Yu-Te Wu
HCHeng-Sheng Chao
Heng-Sheng Chao
HCHwa-Yen Chiu
Hwa-Yen Chiu
CLChia-Feng Lu
Chia-Feng Lu
Background: Lung cancer (LC) is a leading cause of cancer-related mortality, and immunotherapy (IO) has shown promise in treating advanced-stage LC. However, identifying patients likely to benefit from IO and monitoring treatment response remains challenging. This study aims to develop a predictive model for progression-free survival (PFS) in LC patients with IO based on clinical features and advanced imaging biomarkers. Materials and methods: A retrospective analysis was conducted on a cohort of 206 LC patients receiving IO treatment. Pre-treatment computed tomography images were used to extract advanced imaging biomarkers, including intratumoral and peritumoral-vasculature radiomics. Clinical features, including age, gene status, hematology, and staging, were also collected. Key radiomic and clinical features for predicting IO outcomes were identified using a two-step feature selection process, including univariate Cox regression and chi-squared test, followed by sequential forward selection. The DeepSurv model was constructed to predict PFS based on clinical and radiomic features. Model performance was evaluated using the area under the time-dependent receiver operating characteristic curve (AUC) and concordance index (C-index). Results: Combining radiomics of intratumoral heterogeneity and peritumoral-vasculature with clinical features demonstrated a significant enhancement (p < 0.001) in predicting IO response. The proposed DeepSurv model exhibited a prediction performance with AUCs ranging from 0.76 to 0.80 and a C-index of 0.83. Furthermore, the predicted personalized PFS curves revealed a significant difference (p < 0.05) between patients with favorable and unfavorable prognoses. Conclusions: Integrating intratumoral and peritumoral-vasculature radiomics with clinical features enabled the development of a predictive model for PFS in LC patients with IO. The proposed model’s capability to estimate individualized PFS probability and differentiate the prognosis status held promise to facilitate personalized medicine and improve patient outcomes in LC.

28 February 2019 in Journal of NeuroEngineering and Rehabilitation
Verified
Journal Article
Open access
PDF file
ICI-Hsuan Chen
I-Hsuan Chen
YYYea-Ru Yang
Yea-Ru Yang
CLChia-Feng Lu
Chia-Feng Lu
WYWang Ray Yau
Wang Ray Yau
A recent study has demonstrated that a turning-based treadmill program yields greater improvements in gait speed and temporal symmetry than regular treadmill training in chronic stroke patients. However, it remains unknown how this novel and challenging gait training shapes the cortico-cortical network and cortico-spinal network during walking in chronic stroke patients. The purpose of this study was to examine how a novel type of gait training, which is an unfamiliar but effective task for people with chronic stroke, enhances brain reorganization. Subjects in the experimental and control groups received 30 min of turning-based treadmill training and regular treadmill training, respectively. Cortico-cortical connectivity and cortico-muscular connectivity during walking and gait performance were assessed before and after completing the 12-session training. Eighteen subjects (n = 9 per group) with a mean age of 52.5 ± 9.7 years and an overground walking speed of 0.61 ± 0.26 m/s consented and participated in this study. There were significant group by time interactions for gait speed, temporal gait symmetry, and cortico-cortical connectivity as well as cortico-muscular connectivity in walk-related frequency (24–40 Hz) over the frontal-central-parietal areas. Compared with the regular treadmill training, the turning-based treadmill training resulted in greater improvements in these measures. Moreover, the increases in cortico-cortical connectivity and cortico-muscular connectivity while walking were associated with improvements in temporal gait symmetry. Our findings suggest this novel turning-based treadmill training is effective for enhancing brain functional reorganization underlying cortico-cortical and corticomuscular mechanisms and thus may result in gait improvement in people with chronic stroke. ACTRN12617000190303 . Registered 3 February 2017, retrospectively registered.